🇺🇸 FDA
Patent

US 10829486

Isoxazole derivatives as FXR agonists and methods of use thereof

granted A61PA61P1/16A61P13/12

Quick answer

US patent 10829486 (Isoxazole derivatives as FXR agonists and methods of use thereof) held by Enanta Pharmaceuticals, Inc. expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Enanta Pharmaceuticals, Inc.
Grant date
Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P1/16, A61P13/12, A61P3/04, A61P3/10